52 /100
HIGH RISK
Score updated May 30, 2026

REVB — Revelation Biosciences, Inc. Dilution Risk Tracker

Track REVB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track REVB — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
27
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
48%
🔁 Convertible Conversion 60%
• Major convertible overhang: 58% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration 40%
• Score rose 32 points recently (worsening)
🔄 Reverse Split 30%
• 50-day avg $1.13 approaching $1 threshold
🔔 Track REVB — Get forecast alerts →

💹 Market Data

Market Cap$4.28M
Shares Outstanding3.91M
Float3.44M
Cash$14.11M
Debt$759.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 223.8% shares (2025Q4 vs prior)
13 institutional holders · 1.23M shares
#1 SABBY MANAGEMENT, LLC 605.7K shares
#2 ARMISTICE CAPITAL, LLC 434.3K shares
#3 CITADEL ADVISORS LLC 54.7K shares
+ 10 more holders Sign up free to view →

📉 Short Interest

Short Interest34.5K
Days to Cover1.0
% of Float1.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2022
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track REVB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking REVB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for REVB
📊 REVB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 REVB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.